Showing 1 - 7 results of 7 for search 'Thomas Schaser', query time: 0.03s Refine Results
  1. 1
    Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma

    Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma by Karin Teppert, Nora Winter, Vera Herbel, Caroline Brandes, Simon Lennartz, Fabian Engert, Andrew Kaiser, Thomas Schaser, Dominik Lock

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer

    Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer by Nicole Cordes, Nora Winter, Carolin Kolbe, Bettina Kotter, Joerg Mittelstaet, Mario Assenmacher, Toni Cathomen, Andrew Kaiser, Thomas Schaser

    Published 2022-09-01
    Get full text
    Article
  3. 3
    CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes

    CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes by Laura Kapitza, Laura Kapitza, Naphang Ho, Thomas Kerzel, Annika M. Frank, Frederic B. Thalheimer, Arezoo Jamali, Thomas Schaser, Christian J. Buchholz, Christian J. Buchholz, Christian J. Buchholz, Jessica Hartmann

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells

    Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells by Nicole Cordes, Carolin Kolbe, Dominik Lock, Tatjana Holzer, Deborah Althoff, Daniel Schäfer, Franziska Blaeschke, Bettina Kotter, Sandra Karitzky, Claudia Rossig, Toni Cathomen, Tobias Feuchtinger, Iris Bürger, Mario Assenmacher, Thomas Schaser, Andrew D. Kaiser

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Automated generation of gene-edited CAR T cells at clinical scale

    Automated generation of gene-edited CAR T cells at clinical scale by Jamal Alzubi, Dominik Lock, Manuel Rhiel, Sabrina Schmitz, Stefan Wild, Claudio Mussolino, Markus Hildenbeutel, Caroline Brandes, Julia Rositzka, Simon Lennartz, Simone A. Haas, Kay O. Chmielewski, Thomas Schaser, Andrew Kaiser, Toni Cathomen, Tatjana I. Cornu

    Published 2021-03-01
    Get full text
    Article
  6. 6
    Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy

    Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy by Isabella Elias Yonezawa Ogusuku, Vera Herbel, Simon Lennartz, Caroline Brandes, Eva Argiro, Caroline Fabian, Carola Hauck, Conny Hoogstraten, Sabrina Veld, Lois Hageman, Karin Teppert, Georgia Koutsoumpli, Marieke Griffioen, Nadine Mockel-Tenbrinck, Thomas Schaser, Rosa de Groot, Ian C.D. Johnston, Dominik Lock

    Published 2024-06-01
    Get full text
    Article
  7. 7
    Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells

    Combined targeting of soluble latent TGF-ß and a solid tumor-associated antigen with adapter CAR T cells by Niels Werchau, Bettina Kotter, Elvira Criado-Moronati, Andre Gosselink, Nicole Cordes, Dominik Lock, Simon Lennartz, Carolin Kolbe, Nora Winter, Karin Teppert, Fabian Engert, Brian Webster, Joerg Mittelstaet, Daniel Schaefer, Peter Mallmann, Michael R. Mallmann, Dominik Ratiu, Mario Assenmacher, Thomas Schaser, Michael von Bergwelt-Baildon, Pierre Abramowski, Andrew D. Kaiser

    Published 2022-12-01
    Get full text
    Article

Search Tools: